Physician profile
Rachel Sievert
NPI 1043639404
$1,938.96
in general payments reported to CMS, 2019-2025
30 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.54 · 2020: $135 · 2021: $308 · 2022: $465 · 2023: $399 · 2024: $234 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.16 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $215.03 | 2023-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $176.17 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $140.63 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $100.42 | 2021-2024 | |
| Organon LLC | $98.86 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $87.69 | 2023-2025 | Phexxi, Solosec, Phexx |
| Lupin INC. | $79.94 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $76.02 | 2023-2024 | Myfembree |
| Medtronic, INC. | $68.91 | 2022 | |
| Hologic Sales and Service, LLC | $54.36 | 2024-2025 | Thinprep 2000 Processor, Aptima, Fluent Fluid Management System |
| Allergan, INC. | $50.45 | 2020 | |
| Therapeuticsmd, INC. | $48.00 | 2019-2021 | |
| Exact Sciences Corporation | $45.23 | 2025 | Cologuard Collection Kit |
| Apollo Endosurgery US INC | $43.04 | 2023 | Overstitch Endoscopic Suturing System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $37.48 | 2022 | |
| Dysis Medical, INC. | $35.13 | 2021 | |
| Shield Therapeutics INC | $34.53 | 2025 | |
| Avion Pharmaceuticals | $28.38 | 2021 | |
| Smith+Nephew, INC. | $25.97 | 2024 | Pico 7 |
| Roche Diagnostics Corporation | $25.90 | 2019 | |
| Myovant Sciences INC. | $25.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.57 | 2022 | |
| Exeltis, USA INC. | $24.00 | 2025 | Slynd |
| Aspira Women'S Health INC | $20.22 | 2024 | Ova1 |
| Millicent US INC | $19.44 | 2023 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $17.39 | 2021 | |
| Optumhealth Care Solutions, LLC | $15.90 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Mylan Pharmaceuticals INC. | $12.55 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Sievert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.